BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37532520)

  • 41. APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion.
    Nowarski R; Kotler M
    Cancer Res; 2013 Jun; 73(12):3494-8. PubMed ID: 23598277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression.
    Yamazaki H; Shirakawa K; Matsumoto T; Kazuma Y; Matsui H; Horisawa Y; Stanford E; Sarca AD; Shirakawa R; Shindo K; Takaori-Kondo A
    PLoS One; 2020; 15(1):e0223463. PubMed ID: 31914134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. APOBEC3B is preferentially expressed at the G2/M phase of cell cycle.
    Hirabayashi S; Shirakawa K; Horisawa Y; Matsumoto T; Matsui H; Yamazaki H; Sarca AD; Kazuma Y; Nomura R; Konishi Y; Takeuchi S; Stanford E; Kawaji H; Murakawa Y; Takaori-Kondo A
    Biochem Biophys Res Commun; 2021 Mar; 546():178-184. PubMed ID: 33592502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses.
    Verhalen B; Starrett GJ; Harris RS; Jiang M
    J Virol; 2016 Jul; 90(14):6379-6386. PubMed ID: 27147740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single-stranded DNA binding proteins influence APOBEC3A substrate preference.
    Brown AL; Collins CD; Thompson S; Coxon M; Mertz TM; Roberts SA
    Sci Rep; 2021 Oct; 11(1):21008. PubMed ID: 34697369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression.
    Wang D; Li X; Li J; Lu Y; Zhao S; Tang X; Chen X; Li J; Zheng Y; Li S; Sun R; Yan M; Yu D; Cao G; Yang Y
    Gut; 2019 Oct; 68(10):1846-1857. PubMed ID: 31154396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. APOBEC mutagenesis and selection for NFE2L2 contribute to the origin of lung squamous-cell carcinoma.
    Cannataro VL; Kudalkar S; Dasari K; Gaffney SG; Lazowski HM; Jackson LK; Yildiz I; Das RK; Gould Rothberg BE; Anderson KS; Townsend JP
    Lung Cancer; 2022 Sep; 171():34-41. PubMed ID: 35872531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA replication stress: a source of APOBEC3B expression in breast cancer.
    Cescon DW; Haibe-Kains B
    Genome Biol; 2016 Sep; 17(1):202. PubMed ID: 27716362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.
    Caswell DR; Gui P; Mayekar MK; Law EK; Pich O; Bailey C; Boumelha J; Kerr DL; Blakely CM; Manabe T; Martinez-Ruiz C; Bakker B; De Dios Palomino Villcas J; I Vokes N; Dietzen M; Angelova M; Gini B; Tamaki W; Allegakoen P; Wu W; Humpton TJ; Hill W; Tomaschko M; Lu WT; Haderk F; Al Bakir M; Nagano A; Gimeno-Valiente F; de Carné Trécesson S; Vendramin R; Barbè V; Mugabo M; Weeden CE; Rowan A; McCoach CE; Almeida B; Green M; Gomez C; Nanjo S; Barbosa D; Moore C; Przewrocka J; Black JRM; Grönroos E; Suarez-Bonnet A; Priestnall SL; Zverev C; Lighterness S; Cormack J; Olivas V; Cech L; Andrews T; Rule B; Jiao Y; Zhang X; Ashford P; Durfee C; Venkatesan S; Temiz NA; Tan L; Larson LK; Argyris PP; Brown WL; Yu EA; Rotow JK; Guha U; Roper N; Yu J; Vogel RI; Thomas NJ; Marra A; Selenica P; Yu H; Bakhoum SF; Chew SK; Reis-Filho JS; Jamal-Hanjani M; Vousden KH; McGranahan N; Van Allen EM; Kanu N; Harris RS; Downward J; Bivona TG; Swanton C
    Nat Genet; 2024 Jan; 56(1):60-73. PubMed ID: 38049664
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.
    Cheng AZ; Moraes SN; Attarian C; Yockteng-Melgar J; Jarvis MC; Biolatti M; Galitska G; Dell'Oste V; Frappier L; Bierle CJ; Rice SA; Harris RS
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Replication catastrophe induced by cyclic hypoxia leads to increased APOBEC3B activity.
    Bader SB; Ma TS; Simpson CJ; Liang J; Maezono SEB; Olcina MM; Buffa FM; Hammond EM
    Nucleic Acids Res; 2021 Jul; 49(13):7492-7506. PubMed ID: 34197599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort.
    Vitiello GAF; de Sousa Pereira N; Amarante MK; Banin-Hirata BK; Campos CZ; de Oliveira KB; Losi-Guembarovski R; Watanabe MAE
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1523-1532. PubMed ID: 32285256
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.
    Law EK; Sieuwerts AM; LaPara K; Leonard B; Starrett GJ; Molan AM; Temiz NA; Vogel RI; Meijer-van Gelder ME; Sweep FC; Span PN; Foekens JA; Martens JW; Yee D; Harris RS
    Sci Adv; 2016 Oct; 2(10):e1601737. PubMed ID: 27730215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.
    Roberts SA; Lawrence MS; Klimczak LJ; Grimm SA; Fargo D; Stojanov P; Kiezun A; Kryukov GV; Carter SL; Saksena G; Harris S; Shah RR; Resnick MA; Getz G; Gordenin DA
    Nat Genet; 2013 Sep; 45(9):970-6. PubMed ID: 23852170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Small-Angle X-ray Scattering Models of APOBEC3B Catalytic Domain in a Complex with a Single-Stranded DNA Inhibitor.
    Barzak FM; Ryan TM; Kvach MV; Kurup HM; Aihara H; Harris RS; Filichev VV; Harjes E; Jameson GB
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33673243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Repair of base damage within break-induced replication intermediates promotes kataegis associated with chromosome rearrangements.
    Elango R; Osia B; Harcy V; Malc E; Mieczkowski PA; Roberts SA; Malkova A
    Nucleic Acids Res; 2019 Oct; 47(18):9666-9684. PubMed ID: 31392335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.
    Byeon IJ; Byeon CH; Wu T; Mitra M; Singer D; Levin JG; Gronenborn AM
    Biochemistry; 2016 May; 55(21):2944-59. PubMed ID: 27163633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The choice of nucleotide inserted opposite abasic sites formed within chromosomal DNA reveals the polymerase activities participating in translesion DNA synthesis.
    Chan K; Resnick MA; Gordenin DA
    DNA Repair (Amst); 2013 Nov; 12(11):878-89. PubMed ID: 23988736
    [TBL] [Abstract][Full Text] [Related]  

  • 59. APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells.
    Shinohara M; Io K; Shindo K; Matsui M; Sakamoto T; Tada K; Kobayashi M; Kadowaki N; Takaori-Kondo A
    Sci Rep; 2012; 2():806. PubMed ID: 23150777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B.
    Shi K; Demir Ö; Carpenter MA; Wagner J; Kurahashi K; Harris RS; Amaro RE; Aihara H
    Sci Rep; 2017 Dec; 7(1):17415. PubMed ID: 29234087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.